Clinical evaluation of human telomerase catalytic subunit in bladder washings from patients with bladder cancer.

PURPOSE We examined the expression of mRNA of human telomerase reverse transcriptase (hTERT), a catalytic subunit of the telomerase complex, in bladder washings as a tumor marker for the detection of bladder cancer. MATERIALS AND METHODS Bladder washings were obtained from 63 patients. We examined the expression of hTERT mRNA by the nested reverse transcription-polymerase chain reaction (RT-PCR) method and also measured the relative expressions of hTERT mRNA and beta(2)-microglobulin (beta(2)-MG) in these samples by RT-PCR analysis. Correlations between the relative expression of hTERT mRNA and clinical features were analyzed. We also compared the sensitivity of this assay with that of urinary cytology. RESULTS By nested RT-PCR, we detected three false-positive cases (11%) in the control group. Therefore, the relative expression values of hTERT mRNA and beta(2)-MG correlated strongly with tumor size, but not with multiplicity or histologic grade. When the cut-off value of the expression was fixed at 0.27%, the sensitivity and specificity of this assay were 74% and 93%, respectively. This assay was more sensitive than urinary cytology for the detection of bladder cancer. CONCLUSION These results suggest that the relative expression of hTERT mRNA in bladder washings is useful in screening for bladder cancer. Relative expression is of assistance in diagnosing bladder cancer.

[1]  Okuyama,et al.  WT1 Gene Expression in Human Testicular Germ-Cell Tumors. , 1999, Molecular urology.

[2]  J. Shay,et al.  Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  S. Kyo,et al.  Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  M. Marberger,et al.  Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer? , 1998, The Journal of urology.

[5]  S. Kyo,et al.  Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. , 1998, Cancer research.

[6]  Y. Shinkai,et al.  Expression profile of the putative catalytic subunit of the telomerase gene. , 1998, Cancer research.

[7]  H. Stein,et al.  Non‐radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine , 1998 .

[8]  F. Ishikawa,et al.  Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas , 1998, Nature Genetics.

[9]  W. Murphy,et al.  The bladder tumor antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms. , 1997, The Journal of urology.

[10]  M. Lundie,et al.  Rapid detection of bladder cancer: a comparative study of point of care tests. , 1997, The Journal of urology.

[11]  M. Bass,et al.  Human telomerase contains evolutionarily conserved catalytic and structural subunits. , 1997, Genes & development.

[12]  D. Bowtell,et al.  Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. , 1997, Human molecular genetics.

[13]  R. Weinberg,et al.  hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization , 1997, Cell.

[14]  C B Harley,et al.  Telomerase catalytic subunit homologs from fission yeast and human. , 1997, Science.

[15]  A. Matsuura,et al.  TLP1: A Gene Encoding a Protein Component of Mammalian Telomerase Is a Novel Member of WD Repeats Family , 1997, Cell.

[16]  Lea Harrington,et al.  A Mammalian Telomerase-Associated Protein , 1997, Science.

[17]  Kazuhiro Yoshida,et al.  Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine , 1997, Cancer.

[18]  G. Kimura,et al.  Clinical evaluation of soluble cytokeratin 19 fragments (CYFRA 21-1) in serum and urine of patients with bladder cancer. , 1996, Urology.

[19]  G. Capitanio,et al.  Standardization of assay for cytokeratin-related tumor marker CYFRA21.1 in urine samples. , 1996, Clinical chemistry.

[20]  A. Gazdar,et al.  Telomerase activity in human breast tumors. , 1996, Journal of the National Cancer Institute.

[21]  et al.,et al.  The RNA component of human telomerase , 1995, Science.

[22]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[23]  W. Frable,et al.  Current practice of urinary bladder cytology. , 1977, Cancer research.